Joël St-Aubin, PhD

Clinical Associate Professor of Radiation Oncology

Introduction

BSc, Honors Physics, Dalhousie University, Halifax NS PhD, Medical Physics, University of Alberta, Edmonton AB

Current Positions

Clinical Associate Professor of Radiation Oncology
Director of Clinical Medical Physics Residency Program, Department of Radiation Oncology

Education

Bachelor's of Science in Honors Physics, Dalhousie University, Halifax, Canada
Doctor of Philosophy in Medical Physics, University of Alberta, Edmonton, Canada

Research Interests

Adaptive MRI Guided Radiotherapy

Licenses & Certifications

Member- Canadian College of Physicists in Medicine, Canada
Fellow- Canadian College of Physicists in Medicine, Canada

Selected Publications

Swan A, Yang R, Zelyak O, St-Aubin J. Feasibility of streamline upwind Petrov-Galerkin angular stabilization of the linear Boltzmann transport equation with magnetic fields. Biomed Phys Eng Express. 2020 Dec 21;7(1). doi: 10.1088/2057-1976/abd239. PMID: 34037544.
Strand S, Boczkowski A, Smith B, Snyder JE, Hyer DE, Yaddanapudi S, Dunkerley DAP, St-Aubin J. Analysis of patient-specific quality assurance for Elekta Unity adaptive plans using statistical process control methodology. J Appl Clin Med Phys. 2021 Apr;22(4):99-107. doi: 10.1002/acm2.13219. Epub 2021 Mar 23. PMID: 33756059; PMCID: PMC8035570.
Petronek MS, St-Aubin JJ, Lee CY, Spitz DR, Gillan EG, Allen BG, Magnotta VA. Quantum chemical insight into the effects of the local electron environment on T₂*-based MRI. Sci Rep. 2021 Oct 21;11(1):20817. doi: 10.1038/s41598-021-00305-7. PMID: 34675308; PMCID: PMC8531323.
Dunkerley DAP, Hyer DE, Snyder JE, St-Aubin JJ, Anderson CM, Caster JM, Smith MC, Buatti JM, Yaddanapudi S. Clinical Implementational and Site-Specific Workflows for a 1.5T MR-Linac. J Clin Med. 2022 Mar 16;11(6):1662. doi: 10.3390/jcm11061662. PMID: 35329988; PMCID: PMC8954784.
Snyder JE, St-Aubin J, Yaddanapudi S, Marshall S, Strand S, Kruger S, Flynn R, Hyer DE. Reducing MRI-guided radiotherapy planning and delivery times via efficient leaf sequencing and segment shape optimization algorithms. Phys Med Biol. 2022 Feb 24;67(5). doi: 10.1088/1361-6560/ac5299. PMID: 35130528.
Kozak MM, Crompton D, Gross BA, Harshman L, Dickens D, Snyder J, Shepard A, St-Aubin J, Dunkerley D, Hyer D, Buatti JM. Initial clinical applications treating pediatric and adolescent patients using MR-guided radiotherapy. Front Oncol. 2022 Nov 7;12:962926. doi: 10.3389/fonc.2022.962926. PMID: 36419881; PMCID: PMC9676495.
Petronek MS, Teferi N, Caster JM, Stolwijk JM, Zaher A, Buatti JM, Hasan D, Wafa EI, Salem AK, Gillan EG, St-Aubin JJ, Buettner GR, Spitz DR, Magnotta VA, Allen BG. Magnetite nanoparticles as a kinetically favorable source of iron to enhance GBM response to chemoradiosensitization with pharmacological ascorbate. Redox Biol. 2023 Jun;62:102651. doi: 10.1016/j.redox.2023.102651. Epub 2023 Mar 7. PMID: 36924683; PMCID: PMC10025281.
Snyder J, Smith B, St-Aubin J, Dunkerley D, Shepard A, Caster J, Hyer D. Intra-fraction motion of pelvic oligometastases and feasibility of PTV margin reduction using MRI guided adaptive radiotherapy. Front Oncol. 2023 Apr 19;13:1098593. doi: 10.3389/fonc.2023.1098593. PMID: 37152034; PMCID: PMC10154517.
Hyer DE, Caster J, Smith B, St-Aubin J, Snyder J, Shepard A, Zhang H, Mullan S, Geoghegan T, George B, Byrne J, Smith M, Buatti JM, Sonka M. A Technique to Enable Efficient Adaptive Radiation Therapy: Automated Contouring of Prostate and Adjacent Organs. Adv Radiat Oncol. 2023 Aug 7;9(1):101336. doi: 10.1016/j.adro.2023.101336. PMID: 38260219; PMCID: PMC10801646.
Petronek MS, Monga V, Bodeker KL, Kwofie M, Lee CY, Mapuskar KA, Stolwijk JM, Zaher A, Wagner BA, Smith MC, Vollstedt S, Brown H, Chandler ML, Lorack AC, Wulfekuhle JS, Sarkaria JN, Flynn RT, Greenlee JDW, Howard MA, Smith BJ, Jones KA, Buettner GR, Cullen JJ, St-Aubin J, Buatti JM, Magnotta VA, Spitz DR, Allen BG. Magnetic Resonance Imaging of Iron Metabolism with T2* Mapping Predicts an Enhanced Clinical Response to Pharmacologic Ascorbate in Patients with GBM. Clin Cancer Res. 2024 Jan 17;30(2):283-293. doi: 10.1158/1078-0432.CCR-22-3952. PMID: 37773633; PMCID: PMC10841843.